subscribe
 

Oncology research and development

PRECOS launch portfolio of techniques and models of acquired resistance to targeted agents and standards of care used in oncology at AACR Annual Meeting 2013

Focusing on nanopores with PI’s precision positioning stages

Scientists at the University of Cambridge are using Physik Instrumente’s P-517 3-axis precision nanopositioning system to further advance...

Nerve cells grow on nanocellulose

Researchers from Chalmers and the University of Gothenburg have shown that nanocellulose stimulates the formation of neural networks. This...

Researchers demonstrate versatility of solid-state protein sensor

A novel type of sensor, based on nanometer-scale pores in a semiconductor membrane, is a step closer to practical use in applications such...

European multiple sclerosis market in dire need of increased disease awareness and treatment options, cautions Frost & Sullivan

Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis market.

Frutarom boosts production of natural cosmetic

Frutarom, Israel, expanded its new, environment-friendly algae plant in the Negev desert to answer increasing demands for Alguard, the company’s natural and sustainable “skin-active shield” ingredient derived from red microalgae...

Enhanced facilities spur the drive of emerging technologies

ACHEMA 2012 is close to being a sell-out event which will provide a global showcase for innovation and emerging technologies in the chemical engineering, environmental protection and biotechnology sectors.

3Rs science has moved from margin to mainstream

UK commitment to discovering laboratory methods that reduce the reliance on animal use and improve animal welfare (known as the 3Rs) is stronger than ever before.

Free trial of STEM Integrity 10 Reaction Station

Electrothermal’s STEM Integrity 10 Reaction Station enables ten experiments to be run simultaneously within the same unit, each with its...

New barcode library allows multiplexing of up to 96 different samples in a single sequencing run

Fluidigm Corporation has announced the availability of the Access Array™ Barcode Library for the Ion Torrent Personal Genome Machine (PGM)...

OGT develops optimised rare disease sequencing and analysis service

Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare...

New international genome research centre to open in Denmark

BGI Europe, a subsidiary of the leading Chinese genomic organisation previously known as Beijing Genomics Institute, will open its first...

Vela and Anagnostics enter strategic partnership

Viennese Vela Laboratories are among the leading companies offering efficacy and release testing for biopharmaceuticals under GMP...

Bio economy grows at Reims Management School

Reims Management School has launched a new chair dedicated to agri-bio-industrial research, confirming its contribution to the development of the bio-based economy, one of Europe’s most important growth markets.

Scientists reveal how cholera bacterium gains a foothold in the gut

A team of biologists at the University of York has made an important advance in our understanding of the way cholera attacks the body.

Thousands of dogs and other animals spared cruel chemical tests in Europe

Humane Society International/Europe is celebrating a change in European law on biocides (non-food pesticides) that will save tens of thousands of dogs, rabbits and rodents from painful and lethal chemical poisoning tests - the largest...

Highly specific Lp(a) assay from Randox available for chemistry analysers

The Randox liquid ready to use Lipoprotein (a) assay provides a highly sensitive and specific method for the detection of Lp(a) in human serum and plasma.

Trophos launches first study of olesoxime in Multiple Sclerosis patients

Trophos SA announces the initiation of a phase 1b study of olesoxime in multiple sclerosis (MS) patients as a complementary therapy to their treatment with interferon beta.

PPPs standing behind the growth of pharma R&D

In the past years, many blockbuster drugs lost their patents. To avoid the resulting decline in sales, pharma companies had to start looking for new wonder drugs. Considering the main factors such as time horizon and financial resources,...

Almac’s clinical trial workshop series to return in 2013

The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.”

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe